How to Capitalize on Europe’s Exploding CBD Market
December 28th, 2021
App, Exclusive, News, Top Story
Europe is the second-largest CBD market in the world after North America, with over 500 million potential customers. According to Brightfield Group, the European CBD market will grow from €270 million in 2018 to €1.4 billion by 2023, representing a blistering 42% compound annual growth rate, making it one of the fastest-growing markets.
While European regulators debate CBD classifications, hemp-based CBD is legal in most countries as long as it contains <0.2% THC. Many large CBD companies are waiting on the sidelines for clear European Union guidelines, but smaller companies are increasingly entering the space and building a lucrative market presence.
The North American CBD market is already well-established after the 2018 Farm Bill removed hemp from the DEA’s list of controlled substances. As the U.S. and Canadian markets mature, many companies are looking to expand into faster-growing markets—like Europe. And, their operational experience could give them a significant leg up.
CBD Life Sciences Inc. (OTC Pink: CBDL) recently announced plans to expand its hemp product line into Europe. In particular, it hopes to expand its retail division into France, Italy, and Switzerland to reach more customers and build an international base of operations. Aside from Germany and the U.K., these are among the largest regional markets.
“There are many perks when it comes to taking a company global and we have been working diligently to eventually make this happen,” says CEO Lisa Nelson. “By taking our business global, we will have access to a much larger base of customers, and this is a wonderful opportunity to take our revenues to an all-time high.”
CBD Life Sciences operates retail CBD locations in Arizona and an online platform. In addition, the company is pioneering the development of CBD vending machines to reach customers with less capital expense than a brick-and-mortar location. The company also recently launched a Bitcoin vending machine to draw customers to its retail locations.
Investing in Domestic Startups
The rising interest in CBD across Europe has spawned many startups across the region. For instance, Germany’s Sanity Group raised more than $20 million to launch its wellness brand, VAAY, and pharmaceutical brand, Vayamed, sold in German beauty stores and online. The company even launched a series of television ads.
Many European startups have also become acquisition targets for multi-national CBD companies. For example, World High Life acquired U.K. CBD brand Love Hemp for £9 million and invested £2 million into the business following the 2019 acquisition. These kinds of deals could become even more common over time as the market matures.
Europe’s CBD market already represents over 30% of the global market—just shy of North America’s 40% market share. Investors interested in the space may want to consider U.S. companies expanding into the region, such as CBD Life Sciences Inc. (OTC Pink: CBDL), while high net worth investors might participate in European startup rounds.
To learn more about CBD Life Sciences, visit the company’s website at www.lbcbioscienceinc.com.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.